U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
RIPERTAMAB
INN  
Official Name English
SCT400
Code English
IMMUNOGLOBULIN IGG1, ANTI-(HUMAN CD20 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL DISULFIDE SCT400 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SCT400 .KAPPA.-CHAIN, DIMER
Common Name English
Ripertamab [WHO-DD]
Common Name English
SCT-400
Code English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS MS4A1 (MEMBRANE-SPANNING 4-DOMAINS SUBFAMILY A MEMBER 1, CD20)), CHIMERIC MONOCLONAL ANTIBODY
Common Name English
ripertamab [INN]
Common Name English
Code System Code Type Description
INN
11212
Created by admin on Sat Dec 16 15:24:10 GMT 2023 , Edited by admin on Sat Dec 16 15:24:10 GMT 2023
PRIMARY
NCI_THESAURUS
C122680
Created by admin on Sat Dec 16 15:24:10 GMT 2023 , Edited by admin on Sat Dec 16 15:24:10 GMT 2023
PRIMARY
CAS
2249927-04-4
Created by admin on Sat Dec 16 15:24:10 GMT 2023 , Edited by admin on Sat Dec 16 15:24:10 GMT 2023
PRIMARY
CLINICAL_TRIALS.GOV
NCT02456207
Created by admin on Sat Dec 16 15:24:10 GMT 2023 , Edited by admin on Sat Dec 16 15:24:10 GMT 2023
PRIMARY
FDA UNII
URS0374MIV
Created by admin on Sat Dec 16 15:24:10 GMT 2023 , Edited by admin on Sat Dec 16 15:24:10 GMT 2023
PRIMARY
ACTIVE MOIETY
RIPERTAMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966